Sun Pharmaceutical Stock Screener

loading widget totrade SUNPHARMA

SWOT Analysis

What is SWOT Analysis right arrow
Sun Pharmaceutical Industries Ltd.
Strengths right arrow 13 S
Weakness right arrow 8 W
Opportunity right arrow 8 O
Threats right arrow 2 T
What is SWOT Analysis ?
Strengths, Weaknesses, Opportunities and Threats Analysis is a real time check on stock health throughout the day. SWOT looks at financials, management quality, technical parameters and valuations to identify positives and negatives for every stock.
These are then classified as strengths, weaknesses, opportunities that investors can leverage, and threats that might impact company health.
  • Strengths
  • Weakness
  • Opportunity
  • Threats
  • Benjamin Graham Value Screen
  • Consistent Highest Return Stocks over Five Years
  • Mid-range Performer (DVM)
  • Stocks with Consistent Share Price Growth (subscription)
  • PEG lower than Industry PEG
  • High Momentum Scores (Technical Scores greater than 50)
  • Effectively using its capital to generate profit - RoCE improving in last 2 years
  • Efficient in managing Assets to generate Profits - ROA improving since last 2 year
  • Companies with Low Debt
  • Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
  • Annual Net Profits improving for last 2 years
  • Book Value per share Improving for last 2 years
  • Top Gainers
  • Stocks with Expensive Valuations according to the Trendlyne Valuation Score
  • Declining profits every quarter for the past 2 quarters
  • Declining Net Cash Flow : Companies not able to generate net cash
  • Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)
  • Increasing Trend in Non-Core Income
  • High promoter stock pledges
  • Near 52 Week Low
  • Stocks Underperforming their Industry Price Change in the Quarter
  • Companies with Upcoming Results
  • Brokers upgraded recommendation or target price in the past three months
  • Mutual Funds Increased Shareholding in Past Month
  • Street Favorite: High Analyst Rating with at least 20% upside
  • FII / FPI or Institutions increasing their shareholding
  • MFs increased their shareholding last quarter
  • Mutual Funds Increased Shareholding over the Past Two Months
  • Mf buying for 2 months
  • Red Flags: Firms linked to ongoing regulatory investigations/legal cases
  • US FDA Warning Letter
Trendlyne

QVT Stock Score

What is QVT right arrow
Sun Pharmaceutical Industries Ltd.
Quality 91 /100 High Financial Strength
Valuation 36 /100 Mid Valuation
Technicals 52 /100 Technically Neutral
Mid-range Performer
Good
Average
Bad
Trendlyne
Track all markets on TradingView

About Sun Pharmaceutical

Scroll to Top